BrainEver is a operator of a medical research agency intended to offer drugs for the treatment of neurodegenerative disorders.
BrainEver has raised $38.9M in total funding. The most recent round was Series B. The last funding was announced in July 2025.
BrainEver's investors include Critical Path Ventures, European Innovation Council, iBionext, Relyens.
BrainEver is headquartered in Saint-antoine, France.
BrainEver is a operator of a medical research agency intended to offer drugs for the treatment of neurodegenerative disorders.
BrainEver is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BrainEver — Funding & Investors." VCBacked, July 3, 2025, https://www.vcbacked.co/company/brainever. Accessed October 16, 2026.
VCBacked. (2025). BrainEver — Funding & Investors. Retrieved October 16, 2026, from https://www.vcbacked.co/company/brainever
{{cite web |title=BrainEver — Funding & Investors |url=https://www.vcbacked.co/company/brainever |website=VCBacked |access-date=October 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated